-
Amicus Therapeutics Inc. (NASDAQ:FOLD), Cranbury, N.J. Business: Endocrine/Metabolic Promoted: SVP of Business Operations Bradley Campbell to CBO, a newly created position
Published on 1/30/2012
-
Atherotech Diagnostics Lab Inc., Birmingham, Ala. Business: Diagnostic Hired: Joseph Chimera as EVP of scientific development, formerly general manager of clinical trials lab division at Laboratory Corp. of America …
Published on 1/30/2012
-
Blueprint Medicines, Cambridge, Mass. Business: Cancer Hired: Christoph Lengauer as CSO, formerly VP and global head of oncology drug discovery and preclinical development at Sanofi
Published on 1/30/2012
-
Cerulean Pharma Inc., Cambridge, Mass. Business: Drug delivery, Cancer Hired: Chris Guiffre as SVP and CBO, a newly created position, formerly president and CEO of Alvos Therapeutics Inc.
Published on 1/30/2012
-
Cleveland BioLabs Inc. (NASDAQ:CBLI), Buffalo, N.Y. Business: Cancer, Other, Hematology Transitioning: COO Yakov Kogan to interim CEO; he replaces Michael Fonstein, who stepped down as CEO while remaining president
Published on 1/30/2012
-
Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK; BSE:532296), Mumbai, India Business: Generics, Inflammation, Endocrine/Metabolic Hired: Sandeep Gupta as COO, formerly chairman and managing director at Eli Lilly and Co.'s …
Published on 1/30/2012
-
Horizon DiscoveryLtd., Cambridge, U.K. Business: Functional genomics, Pharmacogenetics, Cancer Hired: Eric Rhodes as chief technical officer of gene targeting, formerly business development director for Sigma-…
Published on 1/30/2012
-
Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Dublin, Ireland Business: Neurology, Endocrine/Metabolic Hired: Fintan Keegan as SVP of technical operations, formerly SVP and chief technical officer of Azur Pharma Ltd., which …
Published on 1/30/2012
-
Sirona BiochemCorp. (TSX-V:SBM), Vancouver, B.C. Business: Endocrine/Metabolic Hired: Sean Cunliffe as CBO and a director, formerly SVP of sales and marketing at AngiotechPharmaceuticals Inc.
Published on 1/30/2012
-
Tris PharmaInc., Monmouth Junction, N.J. Business: Drug delivery Hired: Mahdi Fawzi as CSO and EVP of R&D, including regulatory affairs, formerly president of global R&D at Warner Chilcottplc
Published on 1/30/2012
-
Algeta ASA (OSE:ALGETA), Oslo, Norway Business: Cancer Hired: Jeffrey Albers as president of Algeta's Algeta U.S. commercial operation, formerly VP of U.S. hematology and oncology business at Genzyme Corp., which Sanofi…
Published on 1/23/2012
-
Array BioPharma Inc. (NASDAQ:ARRY), Boulder, Colo. Business: Cancer, Inflammation, Chemistry Resigned: Robert Conway as CEO and a director; Chairman Kyle Lefkoff transitioned to executive chairman to oversee the company…
Published on 1/23/2012
-
Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Pharmaceuticals Transitioned: Mike Crooks to general manager of Astellas' Astellas Pharma Europe Ltd. subsidiary's Astellas Pharma Ltd. affiliate from sales and …
Published on 1/23/2012
-
diaDexus Inc. (OTCBB:DDXS), South San Francisco, Calif. Business: Diagnostic Hired: Jean-Frederic Viret as CFO, effective Feb. 1, formerly CFO of XDx Inc.
Published on 1/23/2012
-
GeNO LLC, Cocoa, Fla. Business: Cardiovascular Hired: Kurt Dasse as EVP, formerly president of Levitronix LLC Promoted: Robert Roscigno to EVP from VP
Published on 1/23/2012
-
Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Biopharmaceuticals, Infectious, Pulmonary Hired: Roy Baynes as SVP of oncology therapeutics, formerly VP of global development and therapeutic area head …
Published on 1/23/2012
-
ProsonixLtd., Oxford, U.K. Business: Inflammation, Drug delivery Hired: Rob Crocker as head of regulatory affairs, formerly managing director of pharma consultancy PhRAction
Published on 1/23/2012
-
RaNA Therapeutics Inc., Cambridge, Mass. Business: Pharmacogenetics Appointed: Brian Gallagher, partner at SR One; and Stephen Padgette, VP of R&D investment strategy at Monsanto Co.
Published on 1/23/2012
-
Savient Pharmaceuticals Inc. (NASDAQ:SVNT), East Brunswick, N.J. Business: Endocrine/Metabolic Hired: David Veitch as head of European operations, formerly SVP of European marketing and brand commercialization at …
Published on 1/23/2012
-
Swedish Orphan Biovitrum AB (SSE:SOBI), Stockholm, Sweden Business: Hematology, Endocrine/Metabolic, Neurology Hired: Alan Raffensperger as COO, formerly CEO of Benechill Inc.
Published on 1/23/2012
-
AgendiaB.V., Amsterdam, the Netherlands Business: Diagnostic, Microarrays Hired: Peter Wulff as VP of finance and CFO
Published on 1/16/2012
-
Ampio Pharmaceuticals Inc. (NASDAQ:AMPE), Greenwood Village, Colo. Business: Ophthalmic, Endocrine/Metabolic, Inflammation Departing: CEO Don Wingerter on compassionate leave; he is succeeded by Chairman Michael …
Published on 1/16/2012
-
Baxter International Inc. (NYSE:BAX), Deerfield, Ill. Business: Pharmaceuticals Hired: Jean-Luc Butel as corporate VP and president, international, effective Feb. 20, formerly EVP and group president, international at …
Published on 1/16/2012
-
BG MedicineInc. (NASDAQ:BGMD), Waltham, Mass. Business: Diagnostic, Proteomics, Supply/Service Hired: Eric Bouvier as president, CEO and a director, formerly president of Danaher Corp.'s Leica Microsystems company; he …
Published on 1/16/2012
-
Biocartis S.A., Lausanne, Switzerland Business: Diagnostic Hired: Clark Harrison as COO, formerly VP of global operations for Danaher Corp.'s Leica Microsystems' Biosystems division
Published on 1/16/2012